Ingevity Corp Files DEFA14A Proxy Statement

TL;DR

INGV filed proxy docs on 3/12, looks like they named someone named M.

AI Summary

On March 12, 2025, Ingevity Corporation (INGV) filed a DEFA14A, indicating they issued a press release. The filing mentions Ingevity naming M. Ingevity Corporation is incorporated in Delaware and headquartered in North Charleston, SC.

Why It Matters

This filing is a proxy statement, which means it contains important information for shareholders regarding company decisions and voting matters.

Risk Assessment

Risk Level: low — This is a standard proxy filing (DEFA14A) and does not appear to contain unusual or high-risk information.

Key Players & Entities

• Ingevity Corporation (company) — Registrant
• M (person) — Newly named individual
• 4920 O'HEAR AVENUE (location) — Company Headquarters
• NORTH CHARLESTON, SC (location) — Company Headquarters

FAQ

From the Filing

0001140361-25-008443.txt : 20250312 0001140361-25-008443.hdr.sgml : 20250312 20250312162256 ACCESSION NUMBER: 0001140361-25-008443 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20250312 DATE AS OF CHANGE: 20250312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 25732054 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 DEFA14A 1 ef20045361_defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.      ) Filed by the Registrant   ☒ Filed by a party other than the Registrant   ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☐ Definitive Additional Materials ☒ Soliciting Material Pursuant to §240.14a-12 INGEVITY CORPORATION (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than The Registrant) Payment of Filing Fee (Check the appropriate box): ☒ No fee required. ☐ Fee paid previously with preliminary materials. ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 On March 12, 2025, Ingevity Corporation issued the following press release. Ingevity names Michael N. Shukov as senior vice president and president of Advanced Polymer Technologies Accomplished specialty chemicals executive brings over 25 years of experience transforming business profitability and driving growth in new markets at global companies NORTH CHARLESTON, S.C., Mar 12, 2025 – Ingevity Corporation (NYSE:NGVT) today announced that Michael N. Shukov has been appointed as senior vice president and president, Advanced Polymer Technologies, effective March 12, 2025. He will also join Ingevity’s executive leadership team. Shukov joins Ingevity following more than eight years at PPG Industries, a global producer of advanced coatings, paints and specialty materials for industrial markets, where he most recently served as managing director of PPG Industrial Coatings, EMEA. Over the course of his career, Shukov has held leadership roles at Solvay Group, Dow Chemical Company and Rohm and Haas. “Michael is a proven leader bringing more than 25 years of specialty chemicals experience to Ingevity,” said Ingevity interim CEO, Luis Fernandez-Moreno. “With his global market experience and impressive track record of transforming business profitability, we are confident he is the right leader for Advanced Polymer Technologies to drive efficiencies through operational excellence and accelerate profitable segment growth across product lines and geographies. We are pleased to welcome him to Ingevity’s leadership team.” “I am excited to be joining Ingevity’s Advanced Polymer Technologies business and have long been impressed by its position as a leading global producer of high performance caprolactone,” said Shukov. “In this new role, I look forward to leveraging my experience leading high performing teams to advance strategic penetration of new markets and significantly improve profitability. I am pleased to be joining such a talented management team as we work to advance Ingevity’s strategic action